Skip to product information
1 of 1

GeneBio Systems

Recombinant CLEC2D Monoclonal Antibody

Recombinant CLEC2D Monoclonal Antibody

SKU:AN301970L

Regular price €349,95 EUR
Regular price Sale price €349,95 EUR
Sale Sold out
Shipping calculated at checkout.

Size::50μL

Storage:Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.

Shipping:Ice bag

Exp date:12 months

Category ID_II:Primary Antibodies

Category ID_III:Monoclonal Antibodies;Recombinant Antibodies

Abbreviation:CLEC2D

Target Synonym:LLT;CLEC2D;CLAX;LLT1;OCIL;C type lectin related f;C type lectin superfamily 2;CLC2D;CLEC2D protein;Clec2d5;C-type lectin domain family 2 member D;L LT1;Lectin like NK cell receptor;Lectin like transcript 1;Lectin-like NK cell receptor;Lectin-like transcript 1;LLT-1;member D;Osteoclast inhibitory lectin

Research Areas:Immunology

Conjugation:Unconjugated

Host:Rabbit

Species reactivity:Human;

Application:WB

Isotype:IgG,κ

Clonality:Monoclonal;Recombinant

Clone NO.:A686

UNIProt ID:Q9UHP7

Accession:

Background:C-type lectin domain family 2 member D (CLEC2D), also known as lectin-like transcript 1 (LLT1) and osteoclast inhibitory lectin (OCIL), is a type II transmembrane C-type lectin receptor primarily expressed upon immune cell activation in T cells, B cells, NK cells, and plasmacytoid and monocyte-derived dendritic cells. CLEC2D interacts with NKR-P1A (KLRB1, CD161) on NK cells and some subsets of T cells, inhibiting NK cell cytotoxicity while alternatively inducing proliferation and IFNγ production in T cells. CLEC2D is also expressed by osteoblasts, inhibiting osteoclast formation and bone resorption.

Concentration:1 mg/mL

Immunogen:Recombinant human CLEC2D fragment

Buffer:PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.

Purification method:Protein A purified

Dilution:WB 1:500-1:1000

Calculated MW:22 kDa

ObservedMW:25-35 kDa

View full details